Sensitivity of the Predictive Hypoglycemia Minimizer System to the Algorithm Aggressiveness Factor
暂无分享,去创建一个
Eyal Dassau | Stephen D Patek | Marc D Breton | Francis J Doyle | Daniel A Finan | Thomas W McCann | Boris P Kovatchev | Brian L Levy | Ramakrishna Venugopalan | Daniel A. Finan | F. Doyle | S. Patek | B. Kovatchev | M. Breton | B. Levy | R. Venugopalan | Eyal Dassau
[1] Eyal Dassau,et al. Modular Artificial β-Cell System: A Prototype for Clinical Research , 2008 .
[2] Niels Kjølstad Poulsen,et al. Model-Based Closed-Loop Glucose Control in Type 1 Diabetes: The DiaCon Experience , 2013, Journal of diabetes science and technology.
[3] Roman Hovorka,et al. Day and Night Home Closed-Loop Insulin Delivery in Adults With Type 1 Diabetes: Three-Center Randomized Crossover Study , 2014, Diabetes Care.
[4] Roman Hovorka,et al. Home use of closed-loop insulin delivery for overnight glucose control in adults with type 1 diabetes: a 4-week, multicentre, randomised crossover study. , 2014, The lancet. Diabetes & endocrinology.
[5] Marc D. Breton,et al. Overnight Glucose Control With an Automated, Unified Safety System in Children and Adolescents With Type 1 Diabetes at Diabetes Camp , 2014, Diabetes Care.
[6] Eyal Dassau,et al. Closed-Loop Control Performance of the Hypoglycemia-Hyperglycemia Minimizer (HHM) System in a Feasibility Study , 2014, Journal of diabetes science and technology.
[7] L. Magni,et al. First Use of Model Predictive Control in Outpatient Wearable Artificial Pancreas , 2014, Diabetes Care.
[8] Howard C. Zisser,et al. Clinical Evaluation of a Personalized Artificial Pancreas , 2013, Diabetes Care.
[9] Marc D. Breton,et al. Modular Closed-Loop Control of Diabetes , 2012, IEEE Transactions on Biomedical Engineering.
[10] Roman Hovorka,et al. Closing the loop overnight at home setting: psychosocial impact for adolescents with type 1 diabetes and their parents , 2014, BMJ Open Diabetes Research and Care.
[11] Howard C. Zisser,et al. Feasibility of Outpatient Fully Integrated Closed-Loop Control , 2013, Diabetes Care.
[12] Marc D. Breton,et al. Safety of Outpatient Closed-Loop Control: First Randomized Crossover Trials of a Wearable Artificial Pancreas , 2014, Diabetes Care.
[13] Stephen D Patek,et al. Hypoglycemia Prevention via Pump Attenuation and Red-Yellow-Green “Traffic” Lights Using Continuous Glucose Monitoring and Insulin Pump Data , 2010, Journal of diabetes science and technology.
[14] David M Nathan,et al. Outpatient glycemic control with a bionic pancreas in type 1 diabetes. , 2014, The New England journal of medicine.
[15] David M Nathan,et al. Autonomous and continuous adaptation of a bihormonal bionic pancreas in adults and adolescents with type 1 diabetes. , 2014, The Journal of clinical endocrinology and metabolism.
[16] Aaron J. Kowalski,et al. Can we really close the loop and how soon? Accelerating the availability of an artificial pancreas: a roadmap to better diabetes outcomes. , 2009, Diabetes technology & therapeutics.
[17] W. Kenneth Ward,et al. Automated Control of an Adaptive Bihormonal, Dual-Sensor Artificial Pancreas and Evaluation During Inpatient Studies , 2014, IEEE Transactions on Biomedical Engineering.
[18] E. Atlas,et al. Nocturnal glucose control with an artificial pancreas at a diabetes camp. , 2013, The New England journal of medicine.
[19] Lauren M. Huyett,et al. Closed-Loop Artificial Pancreas Systems: Engineering the Algorithms , 2014, Diabetes Care.
[20] Howard C. Zisser,et al. Fully Integrated Artificial Pancreas in Type 1 Diabetes , 2012, Diabetes.
[21] Malgorzata E. Wilinska,et al. Overnight Closed-Loop Insulin Delivery in Young People With Type 1 Diabetes: A Free-Living, Randomized Clinical Trial , 2014, Diabetes Care.
[22] Marc D. Breton,et al. Effect of Algorithm Aggressiveness on the Performance of the Hypoglycemia-Hyperglycemia Minimizer (HHM) System , 2014, Journal of diabetes science and technology.